Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2263
https://www.valueinhealthjournal.com/article/S1098-3015(14)04193-X/fulltext
Title :
Economic Evaluation of NAB-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for The Management of Metastatic Pancreatic Cancer in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04193-X&doi=10.1016/j.jval.2014.08.2263
First page :
A632
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1721